Allogene Therapeutics Inc. (ALLO)
NASDAQ · Healthcare
Allogene Therapeutics Inc. Cash on Hand 2019–2025
Allogene Therapeutics Inc. annual cash on hand history from 2019 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Allogene Therapeutics Inc. cash on hand as of December 31, 2025: 51.7M, a 31.28% decrease year-over-year.
- Allogene Therapeutics Inc. cash on hand for 2025 were 51.7M, a 31.28% decrease from 2024.
- Allogene Therapeutics Inc. cash on hand for 2024 were 75.2M, a 9.54% decrease from 2023.
- Allogene Therapeutics Inc. cash on hand for 2023 were 83.2M, a 34.33% increase from 2022.
- Allogene Therapeutics Inc. cash on hand for 2022 were 61.9M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Allogene Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $52 |
| 2024 | $75 |
| 2023 | $83 |
| 2022 | $62 |
| 2021 | $173 |
| 2020 | $183 |
| 2019 | $175 |
Allogene Therapeutics Inc. Cash on Hand — FAQ
Allogene Therapeutics Inc. (ALLO) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ALLO's cash on hand history?
The chart and table above show Allogene Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.